BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25496837)

  • 1. Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats.
    Chua S; Lee FY; Tsai TH; Sheu JJ; Leu S; Sun CK; Chen YL; Chang HW; Chai HT; Liu CF; Lu HI; Yip HK
    J Transl Med; 2014 Dec; 12():357. PubMed ID: 25496837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat-role of dipeptidyl peptidase 4 inhibition.
    Sung PH; Chen KH; Li YC; Chiang JY; Lee MS; Yip HK
    Biomed Pharmacother; 2019 Mar; 111():1088-1102. PubMed ID: 30841422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin pretreatment enhances the therapeutic effects of exogenous mitochondria against hepatic ischemia-reperfusion injury in rats through suppression of mitochondrial permeability transition.
    Chen HH; Chen YT; Yang CC; Chen KH; Sung PH; Chiang HJ; Chen CH; Chua S; Chung SY; Chen YL; Huang TH; Kao GS; Chen SY; Lee MS; Yip HK
    J Pineal Res; 2016 Aug; 61(1):52-68. PubMed ID: 26993080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.
    Ihara M; Asanuma H; Yamazaki S; Kato H; Asano Y; Shinozaki Y; Mori H; Minamino T; Asakura M; Sugimachi M; Mochizuki N; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1287-97. PubMed ID: 25747753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Therapy with SS31 and Mitochondria Mitigates Myocardial Ischemia-Reperfusion Injury in Rats.
    Lee FY; Shao PL; Wallace CG; Chua S; Sung PH; Ko SF; Chai HT; Chung SY; Chen KH; Lu HI; Chen YL; Huang TH; Sheu JJ; Yip HK
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats.
    Femia AP; Raimondi L; Maglieri G; Lodovici M; Mannucci E; Caderni G
    Int J Cancer; 2013 Nov; 133(10):2498-503. PubMed ID: 23649733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of melatonin-supported adipose-derived mesenchymal stem cells against small bowel ischemia-reperfusion injury in rat.
    Chang CL; Sung PH; Sun CK; Chen CH; Chiang HJ; Huang TH; Chen YL; Zhen YY; Chai HT; Chung SY; Tong MS; Chang HW; Chen HH; Yip HK
    J Pineal Res; 2015 Sep; 59(2):206-20. PubMed ID: 26013733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4 therapy still offered an additional benefit on reducing transverse aortic constriction-induced cardiac hypertrophy-caused myocardial damage in DPP-4 deficient rats.
    Lu HI; Chung SY; Chen YL; Huang TH; Zhen YY; Liu CF; Chang MW; Chen YL; Sheu JJ; Chua S; Yip HK; Lee FY
    Am J Transl Res; 2016; 8(2):778-98. PubMed ID: 27158369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sitagliptin protects rat kidneys from acute ischemia-reperfusion injury via upregulation of GLP-1 and GLP-1 receptors.
    Chang MW; Chen CH; Chen YC; Wu YC; Zhen YY; Leu S; Tsai TH; Ko SF; Sung PH; Yang CC; Chiang HJ; Chang HW; Chen YT; Yip HK
    Acta Pharmacol Sin; 2015 Jan; 36(1):119-30. PubMed ID: 25500876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury.
    Glorie LL; Verhulst A; Matheeussen V; Baerts L; Magielse J; Hermans N; D'Haese PC; De Meester I; De Beuf A
    Am J Physiol Renal Physiol; 2012 Sep; 303(5):F681-8. PubMed ID: 22718884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DPP-4 enzyme deficiency protects kidney from acute ischemia-reperfusion injury: role for remote intermittent bowel ischemia-reperfusion preconditioning.
    Chen YT; Wallace CG; Yang CC; Chen CH; Chen KH; Sung PH; Chen YL; Chai HT; Chung SY; Chua S; Lee FY; Ko SF; Lee MS; Yip HK
    Oncotarget; 2017 Aug; 8(33):54821-54837. PubMed ID: 28903385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury.
    Reichetzeder C; von Websky K; Tsuprykov O; Mohagheghi Samarin A; Falke LG; Dwi Putra SE; Hasan AA; Antonenko V; Curato C; Rippmann J; Klein T; Hocher B
    Br J Pharmacol; 2017 Jul; 174(14):2273-2286. PubMed ID: 28423178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.
    Sauvé M; Ban K; Momen MA; Zhou YQ; Henkelman RM; Husain M; Drucker DJ
    Diabetes; 2010 Apr; 59(4):1063-73. PubMed ID: 20097729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early administration of cold water and adipose derived mesenchymal stem cell derived exosome effectively protects the heart from ischemia-reperfusion injury.
    Chai HT; Sheu JJ; Chiang JY; Shao PL; Wu SC; Chen YL; Li YC; Sung PH; Lee FY; Yip HK
    Am J Transl Res; 2019; 11(9):5375-5389. PubMed ID: 31632517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical impairment of angiogenesis, endothelial function and circulating number of endothelial progenitor cells in DPP4-deficient rat after critical limb ischemia.
    Sun CK; Leu S; Sheu JJ; Tsai TH; Sung HC; Chen YL; Chung SY; Ko SF; Chang HW; Yip HK
    Stem Cell Res Ther; 2013 Mar; 4(2):31. PubMed ID: 23517567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapy with dapagliflozin and entresto offers an additional benefit on improving the heart function in rat after ischemia-reperfusion injury.
    Ko SF; Sung PH; Yang CC; Chiang JY; Yip HK
    Biomed J; 2023 Jun; 46(3):100546. PubMed ID: 35718305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new combination of sitagliptin and furosemide protects against remote myocardial injury induced by renal ischemia/reperfusion in rats.
    Youssef MI; Mahmoud AA; Abdelghany RH
    Biochem Pharmacol; 2015 Jul; 96(1):20-9. PubMed ID: 25912235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPP4 Inhibition Ameliorates Cardiac Function by Blocking the Cleavage of HMGB1 in Diabetic Mice After Myocardial Infarction.
    Sato A; Suzuki S; Watanabe S; Shimizu T; Nakamura Y; Misaka T; Yokokawa T; Shishido T; Saitoh SI; Ishida T; Kubota I; Takeishi Y
    Int Heart J; 2017 Oct; 58(5):778-786. PubMed ID: 28966327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergic effect of combined cyclosporin and melatonin protects the brain against acute ischemic reperfusion injury.
    Chen KH; Chai HT; Chen CH; Huang CR; Chiang JY; Sung PH; Chu YC; Yip HK
    Biomed Pharmacother; 2021 Apr; 136():111266. PubMed ID: 33465677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart.
    Chinda K; Sanit J; Chattipakorn S; Chattipakorn N
    Diab Vasc Dis Res; 2014 Mar; 11(2):75-83. PubMed ID: 24357666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.